Comparative molecular profiling of the PPARα/γ activator aleglitazar: PPAR selectivity, activity and interaction with cofactors.

Comparative molecular profiling of the PPARα/γ activator aleglitazar: PPAR selectivity, activity and interaction with cofactors.

Item
http://www.wikidata.org/entity/Q39367068
The nuances of atherogenic dyslipidemia in diabetes: focus on triglycerides and current management strategies.The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis.Minireview: Challenges and opportunities in development of PPAR agonistsMolecular Implications of the PPARs in the Diabetic Eye.Observational study of effects of Saroglitazar on glycaemic and lipid parameters on Indian patients with type 2 diabetesEffects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study.Examining the safety of PPAR agonists - current trends and future prospects.Selective peroxisome proliferator-activated receptor α modulators (SPPARMα): the next generation of peroxisome proliferator-activated receptor α-agonistsThe clinical burden of type 2 diabetes in patients with acute coronary syndromes: prognosis and implications for short- and long-term management.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.PPAR-α agonists are still on the rise: an update on clinical and experimental findings.Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: pooled findings from three randomized phase III trials.Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPARα Selective Agonist.Insulin sensitizers in 2013: new insights for the development of novel therapeutic agents to treat metabolic diseases.Effects of peroxisome proliferator activated receptors (PPAR)-γ and -α agonists on cochlear protection from oxidative stress.Predicted Biological Activity of Purchasable Chemical Space.Aleglitazar, a dual peroxisome proliferator-activated receptor-α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial.
P2860

Comparative molecular profiling of the PPARα/γ activator aleglitazar: PPAR selectivity, activity and interaction with cofactors.

Item
http://www.wikidata.org/entity/Q39367068
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Comparative molecular profilin ...... nd interaction with cofactors.
@en
Comparative molecular profilin ...... nd interaction with cofactors.
@nl
type
label
Comparative molecular profilin ...... nd interaction with cofactors.
@en
Comparative molecular profilin ...... nd interaction with cofactors.
@nl
prefLabel
Comparative molecular profilin ...... nd interaction with cofactors.
@en
Comparative molecular profilin ...... nd interaction with cofactors.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Comparative molecular profilin ...... nd interaction with cofactors.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932